Small-Molecule Drug
A low-molecular-weight pharmaceutical, usually chemically synthesized, that can typically be taken orally and cross cell membranes to reach intracellular targets. It contrasts with large biologics and generally faces simpler manufacturing and lower-cost generic competition.
What is a small-molecule drug?
A small-molecule drug is a pharmaceutical compound with a low molecular weight, typically produced through chemical synthesis. Because of their small size, these molecules can usually be taken by mouth and are able to pass through cell membranes to act on targets located inside cells.
This class encompasses a large share of traditional medications, from common pain relievers to many cardiovascular and psychiatric drugs. Their well-defined chemical structure makes them relatively straightforward to characterize and manufacture compared with more complex therapies.
Why do small-molecule drugs matter in the pharmaceutical landscape?
Small-molecule drugs generally face simpler and less costly manufacturing than large biologic products, and their chemistry lends itself to consistent reproduction. Once their patents expire, they can typically be copied as generics, which intensifies price competition and broadens patient access.
This contrast with biologics shapes drug development strategy, pricing, and market dynamics. The lower production cost and oral convenience of many small molecules continue to make them a mainstay of treatment despite the rise of more complex therapeutic classes.
- what is a small-molecule drug
- small molecule drug meaning
- small molecule vs biologic
- small molecule pharmaceutical definition
- small molecule drugs examples
- difference between small molecule and biologic